These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7443175)
1. Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222. Zeller WJ; Eisenbrand G Oncology; 1981; 38(1):39-42. PubMed ID: 7443175 [TBL] [Abstract][Full Text] [Related]
2. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222. Zeller WJ; Eisenbrand G; Fiebig HH J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309 [TBL] [Abstract][Full Text] [Related]
3. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors. Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats. Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea. Zeller WJ; Eisenbrand G; Fiebig HH J Natl Cancer Inst; 1978 Feb; 60(2):345-8. PubMed ID: 621753 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic effects of 13 nitrosoureas on the LSA lymphoma ascites tumor of the C57BL mouse. Feola JM; Maruyama Y Oncology; 1986; 43(6):378-84. PubMed ID: 3808571 [TBL] [Abstract][Full Text] [Related]
8. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level. Weinkam RJ; Dolan ME J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795 [TBL] [Abstract][Full Text] [Related]
9. Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential. Eisenbrand G; Fiebig HH; Zeller WJ Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):279-86. PubMed ID: 136102 [TBL] [Abstract][Full Text] [Related]
10. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity. Chen FX; Bodell WJ; Liang G; Gold B Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592 [TBL] [Abstract][Full Text] [Related]
11. O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia. D'Incalci M; Taverna P; Erba E; Filippeschi S; Potenza D; Mariani L; Citti L; Catapano CV Anticancer Res; 1991; 11(1):115-21. PubMed ID: 2018345 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice. Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705 [TBL] [Abstract][Full Text] [Related]
13. Development of second malignancies in rats after cure of acute leukemia L 5222 by single doses of 2-chloroethylnitrosoureas. Zeller WJ; Schmähl D J Cancer Res Clin Oncol; 1979 Sep; 95(1):83-6. PubMed ID: 227910 [TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system. Osieka R; Glatte P; Pannenbäcker R; Schmidt CG Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420 [TBL] [Abstract][Full Text] [Related]
16. DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response. Bodell WJ J Neurooncol; 2009 Feb; 91(3):257-64. PubMed ID: 18979209 [TBL] [Abstract][Full Text] [Related]
17. In the search for new anticancer drugs, XXI. Spin labeled nitrosoureas. Sosnovsky G; Li SW; Rao NU Z Naturforsch C J Biosci; 1987; 42(7-8):921-31. PubMed ID: 2961152 [TBL] [Abstract][Full Text] [Related]
18. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
19. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities. Eisenbrand G IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062 [TBL] [Abstract][Full Text] [Related]
20. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]